Last reviewed · How we verify
NCT05181072: CEASE
Identify the Usefulness of In-person and Virtual Quit Smoking Programs
NA trial testing Enhanced in-person peer-motivation smoking cessation in Cigarette Smoking in 392 participants. Completed in 23 December 2023.
23 December 2023
Quick facts
| Lead sponsor | Morgan State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 392 |
| Start date | 5 January 2022 |
| Primary completion | 23 December 2023 |
| Estimated completion | 23 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Enhanced in-person peer-motivation smoking cessation
- Virtual peer-motivation smoking cessation
Conditions studied
- Cigarette Smoking — all drugs for Cigarette Smoking →
- Tobacco Use — all drugs for Tobacco Use →
Sponsor
Morgan State University
Who can join
21 and older, any sex, with Cigarette Smoking or Tobacco Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized community-based trial adapted to the needs of adults aged 21 years or older that is designed by an existing research partnership called Communities Engaged and Advocating for Smoke-free Environments (CEASE). The overarching goal of the proposed study is to apply a community-based approach to reduce tobacco use among low-income communities in Baltimore City. The study setting represents three underserved communities in Baltimore City: the Oldtown/Middle East, the Waverlies, Poppleton/The Terraces/Hollins Market, and Washington Village/Pigtown. Poppleton/The Terraces/Hollins Market and Washington Village/Pigtown will be considered as one community. The three communities have been randomly allocated to one of the three arms of the study: 1) Virtual intervention, 2) Enhanced in-person intervention, and 3) The control community. The Waverlies was assigned to virtual, the Middle East was assigned to be the in-person group, and Poppleton/The Terraces/Hollins Market and Washington Village/Pigtown became the self-help/control group. The goal of the trial is to assess the effectiveness of virtual versus in-person versions of a smoking cessation program in terms of their success rates (quitting and staying quit). The study's primary hypothesis is that the smoking cessation rate will be equal to or higher in the virtual peer-motivation arm than the in-person and self-help/ control arms. The secondary hypothesis is that the retention rate will differ among the three interventions (virtual peer-motivation, enhanced in-person peer-motivation, and self-help/control community). Virtual and enhanced in-person versions of the CEASE Today Peer-Motivation Intervention were developed and pilot-tested during the first and second years based on local data and input from partnering communities. The enhanced in-person intervention will utilize the existing CEASE Today Tobacco Cessation Manual with improvements. The virtual intervention will use a newly developed CEASE website with smoking cessation modules and lessons that mirror the CEASE Today Tobacco Cessation Manual. Trained peer-motivators will deliver the intervention and be actively involved in recruiting the participants, motivation enhancement, group facilitation, and counseling.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05181072
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cigarette Smoking
Currently open trials in the same condition.
- NCT07161050 — Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing · NA · recruiting
- NCT07014124 — Smoking Cessation for Fathers of Sick Children · NA · recruiting
- NCT06678789 — Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches · NA · recruiting
- NCT06609083 — Effect of Cannabis on Cigarette Use Behavior · Phase 1 · recruiting
- NCT05587361 — Beta-Adrenergic Modulation of Drug Cue Reactivity · Phase 4 · recruiting
Other Morgan State University trials
Trials by the same sponsor.
- NCT06522685 — Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation · NA · not yet recruiting
- NCT06519487 — Social Experiences and Demographic Factors in the Regulation of Immune Cells · NA · recruiting
- NCT06053762 — Identify the Usefulness of Peer-facilitated Versus Self-navigated Quit Tobacco Program for Youths. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05181072 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Morgan State University
- Last refreshed: 29 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05181072.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing